Urgent.News

What's breaking now, across thousands of outlets.

Health & Medicine

AstraZeneca to Invest $2 Billion in Summit Therapeutics, Collaborate on Cancer Drugs

Summit shares surged in after-hours trading following the news of AstraZeneca’s investment, as the two companies plan to ramp up their collaboration on developing cancer treatments.

AstraZeneca to Invest $2 Billion in Summit Therapeutics, Collaborate on Cancer Drugs

We haven't written up this one. WSJ Markets has the full story — the link below goes straight to it.

Read the original at wsj.com →

More in Health & Medicine

More from Monday 28 September →